Zymeworks Inc.

Zymeworks is a biotechnology company that develops experimental medicines to treat cancer, inflammation, and autoimmune diseases. The company designs antibodies, which are proteins that help the body's immune system fight disease, and attaches toxic drugs to them so they kill cancer cells more effectively. Zymeworks has several experimental drugs in clinical trials, including treatments for breast cancer, prostate cancer, ovarian cancer, lung cancer, liver cancer, and chronic obstructive pulmonary disease. The company partners with larger pharmaceutical companies like Merck, Bristol-Myers Squi…